Hugo Y Hsu1, Benjamin Ernst2, Eric J Schmidt2, Rohit Parihar2, Chelsea Horwood2, Sean L Edelstein2. 1. Doheny Eye Center of UCLA, Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA. Electronic address: hhsu@doheny.org. 2. Department of Ophthalmology, Saint Louis University School of Medicine, St Louis, Missouri, USA.
Abstract
PURPOSE: To evaluate the laboratory results and prognostic factors of poor clinical outcomes in microbial keratitis cases over 15 years at Saint Louis University. DESIGN: Retrospective cohort and trend study. METHODS: Microbiological and clinical information from culture-positive cases seen at Saint Louis University from 1999 to 2013 were reviewed retrospectively. Statistical analyses were used to determine microbiological and antibiotic susceptibility trends. Prognostic factors of poor clinical outcome from the literature were used to create multivariate regression models to describe our cohort. RESULTS: Gram-positive organisms predominated (48%), followed by gram-negative organisms (34%) and fungi (16%). The most commonly isolated organism was Pseudomonas aeruginosa (21%). Oxacillin-resistant rates of Staphylococcus aureus and coagulase-negative staphylococci were 45% and 43%, respectively. Only the proportion of Pseudomonas changed significantly over time (P = .02). The only antibiotic found to lose efficacy over time was gentamicin for gram-positive organisms (P = .005). Multivariate logistic regression analyses revealed that major complications were associated with large ulcers (P < .006), fungal cases (P < .001), and comorbid ophthalmic conditions (P < .001). Poor healing was associated with large ulcers (P < .001) and fungal cases (P < .001). Lastly, poor visual outcome was associated with large ulcers (P < .01) and age ≥ 60 years (P < .02). CONCLUSIONS: In the St Louis area, oxacillin-resistant organisms, Pseudomonas aeruginosa, and fungi are commonly recovered from microbial keratitis cases with a disproportionally high incidence. Hence, empiric antibiotic choice should reflect these trends. Special care needs to be taken for patients with large ulcers and fungal infections, as well as elderly patients with comorbid ophthalmic conditions, as these patients have worse clinical outcomes.
PURPOSE: To evaluate the laboratory results and prognostic factors of poor clinical outcomes in microbial keratitis cases over 15 years at Saint Louis University. DESIGN: Retrospective cohort and trend study. METHODS: Microbiological and clinical information from culture-positive cases seen at Saint Louis University from 1999 to 2013 were reviewed retrospectively. Statistical analyses were used to determine microbiological and antibiotic susceptibility trends. Prognostic factors of poor clinical outcome from the literature were used to create multivariate regression models to describe our cohort. RESULTS: Gram-positive organisms predominated (48%), followed by gram-negative organisms (34%) and fungi (16%). The most commonly isolated organism was Pseudomonas aeruginosa (21%). Oxacillin-resistant rates of Staphylococcus aureus and coagulase-negative staphylococci were 45% and 43%, respectively. Only the proportion of Pseudomonas changed significantly over time (P = .02). The only antibiotic found to lose efficacy over time was gentamicin for gram-positive organisms (P = .005). Multivariate logistic regression analyses revealed that major complications were associated with large ulcers (P < .006), fungal cases (P < .001), and comorbid ophthalmic conditions (P < .001). Poor healing was associated with large ulcers (P < .001) and fungal cases (P < .001). Lastly, poor visual outcome was associated with large ulcers (P < .01) and age ≥ 60 years (P < .02). CONCLUSIONS: In the St Louis area, oxacillin-resistant organisms, Pseudomonas aeruginosa, and fungi are commonly recovered from microbial keratitis cases with a disproportionally high incidence. Hence, empiric antibiotic choice should reflect these trends. Special care needs to be taken for patients with large ulcers and fungal infections, as well as elderly patients with comorbid ophthalmic conditions, as these patients have worse clinical outcomes.
Authors: Lisa Keay; Katie Edwards; Thomas Naduvilath; Hugh R Taylor; Grant R Snibson; Kevin Forde; Fiona Stapleton Journal: Ophthalmology Date: 2005-12-19 Impact factor: 12.079
Authors: Alejandro Lichtinger; Sonia N Yeung; Peter Kim; Maoz D Amiran; Alfonso Iovieno; Uri Elbaz; Judy Y F Ku; Rachel Wolff; David S Rootman; Allan R Slomovic Journal: Ophthalmology Date: 2012-05-23 Impact factor: 12.079
Authors: Haoxing Jin; Walter T Parker; Nathan W Law; Cameron L Clarke; Jordan D Gisseman; Stephen C Pflugfelder; Li Wang; Zaina N Al-Mohtaseb Journal: Br J Ophthalmol Date: 2017-03-23 Impact factor: 4.638
Authors: N Venkatesh Prajna; Tiruvengada Krishnan; Jeena Mascarenhas; Revathi Rajaraman; Lalitha Prajna; Muthiah Srinivasan; Anita Raghavan; Catherine E Oldenburg; Kathryn J Ray; Michael E Zegans; Stephen D McLeod; Travis C Porco; Nisha R Acharya; Thomas M Lietman Journal: JAMA Ophthalmol Date: 2013-04 Impact factor: 7.389
Authors: Penny A Asbell; Kathryn A Colby; Sophie Deng; Peter McDonnell; David M Meisler; Michael B Raizman; John D Sheppard; Daniel F Sahm Journal: Am J Ophthalmol Date: 2008-03-28 Impact factor: 5.258
Authors: Penny A Asbell; Christine M Sanfilippo; Christopher M Pillar; Heleen H DeCory; Daniel F Sahm; Timothy W Morris Journal: JAMA Ophthalmol Date: 2015-12 Impact factor: 7.389
Authors: Jennifer R Cope; Sarah A Collier; Hannah Nethercut; Jefferson M Jones; Kirsten Yates; Jonathan S Yoder Journal: MMWR Morb Mortal Wkly Rep Date: 2017-08-18 Impact factor: 17.586
Authors: Mathias Roth; Paul Goerke; Christoph Holtmann; Andreas Frings; Colin R MacKenzie; Gerd Geerling Journal: Graefes Arch Clin Exp Ophthalmol Date: 2022-06-10 Impact factor: 3.117
Authors: Jeremy J Hoffman; John K G Dart; Surjo K De; Nicole Carnt; Georgia Cleary; Scott Hau Journal: Eye (Lond) Date: 2021-11-05 Impact factor: 4.456